Table of Contents

July 01, 2020; Volume 87,Issue 7

From the Editor

  • Cytokines and the still-baffling clinical biology of COVID-19
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine July 2020, 87 (7) 381-382; DOI: https://doi.org/10.3949/ccjm.87b.07020

    The primary culprit is not certain. Is it all immune damage, or is the continued persistence of coronavirus playing a role?

COVID-19 Curbside Consult

  • Clinical presentation and course of COVID-19
    Ryan Miller, DO and Kristin Englund, MD
    Cleveland Clinic Journal of Medicine July 2020, 87 (7) 384-388; DOI: https://doi.org/10.3949/ccjm.87a.ccc013

    Information about the clinical presentation and course of COVID-19 is rapidly evolving.

  • Cytokine storm and the prospects for immunotherapy with COVID-19
    Leonard H. Calabrese, DO
    Cleveland Clinic Journal of Medicine July 2020, 87 (7) 389-393; DOI: https://doi.org/10.3949/ccjm.87a.ccc008

    Despite gaping holes in our knowledge, treatment is evolving.

The Clinical Picture

  • Firm lesion on the lateral thigh
    Morteza Khodaee, MD, MPH and Eric Kim, MD, PhD
    Cleveland Clinic Journal of Medicine July 2020, 87 (7) 394-395; DOI: https://doi.org/10.3949/ccjm.87a.19107

    A 41-year-old man presented with concern about a lesion he had first noticed 6 years earlier.

  • Mönckeberg medial sclerosis
    Anthony Stack, DO, Sandra Sheffield, DO, Karan Seegobin, MBBS and Satish Maharaj, MBBS
    Cleveland Clinic Journal of Medicine July 2020, 87 (7) 396-397; DOI: https://doi.org/10.3949/ccjm.87a.19085

    A man with chronic kidney disease presents with pain and ulceration of the fingers.

1-Minute Consult

Interpreting Key Trials

  • The role of ISCHEMIA in stable ischemic heart disease
    Nikolaos Spilias, MD, Benjamin Zorach, MD, Kara Denby, MD and Stephen Ellis, MD
    Cleveland Clinic Journal of Medicine July 2020, 87 (7) 401-409; DOI: https://doi.org/10.3949/ccjm.87a.20033

    Decisions regarding treatment of stable ischemic heart disease must remain individualized.

Commentary

  • Stable coronary artery disease: Intervene or not?
    Vinayak Nagaraja, MBBS, MS, MMed (Clin Epi), FRACP and A. Michael Lincoff, MD
    Cleveland Clinic Journal of Medicine July 2020, 87 (7) 410-415; DOI: https://doi.org/10.3949/ccjm.87a.20048

    Stable coronary artery disease needs a patient-centered approach, and one size does not fit all.

Review

  • Glucocorticoid-induced osteoporosis: Insights for the clinician
    Shakaib Hayat, MD and Marina N. Magrey, MD
    Cleveland Clinic Journal of Medicine July 2020, 87 (7) 417-426; DOI: https://doi.org/10.3949/ccjm.87a.19039

    Glucocorticoids cause significant bone loss, predominantly affecting trabecular bone, with consequent fragility fractures.

  • Optimize your documentation to improve Medicare reimbursement
    Ecler Ercole Jaqua, MD, Robert Chi, MD, Wessam Labib, MD, MPH, Marcos Uribe, MD, Juan Najarro, MD and Mary Hanna, MD
    Cleveland Clinic Journal of Medicine July 2020, 87 (7) 427-434; DOI: https://doi.org/10.3949/ccjm.87a.19116

    There’s nothing more frustrating than not getting credit for work performed.

  • Procedures and devices to treat resistant hypertension in chronic kidney disease
    Procedures and devices to treat resistant hypertension in chronic kidney disease
    Rama Dilip Gajulapalli, MD, Johnny Chahine, MD, Florian Rader, MD and Ashish Aneja, MD
    Cleveland Clinic Journal of Medicine July 2020, 87 (7) 435-443; DOI: https://doi.org/10.3949/ccjm.87a.19099

    These treatments show potential. All but renal artery stenting are still experimental.

Editorial

Back to top

In this issue

Jump to